Integra LifeSciences has earned CE mark approval in Europe to market a device used to help patients with diabetes manage their chronic wounds. The Integra Flowable Wound Matrix system, which works by filling deep soft tissue or tunneling wounds, could help reduce the risk of amputation in patients with diabetes.
EU approves Integra's diabetes wound management system
SmartBrief Job Listings for Health Care
|Vice President of Regulatory Affairs||
|Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX||
|Santa Clara, CA|
|Senior Director, Biostatistics||